Tech transfer of Russian Covid vaccine Sputnik V kicks off at Indian sites

In September, DRL and RDIF had tied up to conduct clinical trials and distribute the vaccine in India.

As the first batch of the Russian Covid-19 vaccine Sputnik V arrives in India for clinical trials, the process of technology transfer is on at partner sites of Hyderabad-based pharma major Dr Reddy’s Laboratories (DRL). According to sources, work is on to develop a new version of this vaccine that can be stored at 2 to 8 degrees Celsius. Currently, the vaccines’ cold storage requirements are -18 degrees Celsius.
 
Russian Direct Investment Fund (RDIF) and DRL have tied up for conducting clinical trials of the vaccine candidate in India as well as DRL will also be responsible for distribution